Lupin 2024

Eli Lilly’s Adcirca

Aurobindo receives FDA approval for tadalafil tablets

Aurobindo receives FDA approval for tadalafil tablets

EAST WINDSOR, N.J. — Aurobindo has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application for tadalafil tablets USP, 20 mg. Aurobindo’s tadalafil tablets is an AB-rated generic equivalent to the reference listed drug, Eli Lilly’s Adcirca. Tadalafil is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of pulmonary

PP_1170x120_10-25-21